Tag: Michel Vounatsos
Sage Therapeutics secures $3.1bn worth licensing deal for zuranolone and SAGE-217 with Biogen
Sage Therapeutics has secured a global collaboration and licensing deal worth up to $3.1 billion with Biogen for two of its drug candidates intended for ... Read More